Blount Sally E. 4
4 · ABBOTT LABORATORIES · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Abbott (ABT) Director Sally Blount Receives 2,286 RSU Award
What Happened
- Sally E. Blount, a director of Abbott Laboratories (ABT), received a grant of 2,286 restricted stock units (transaction code A) on April 24, 2026. The units were granted at $0.00 (typical for awards) and are payable in Abbott common shares under the company's 2017 Incentive Stock Program.
Key Details
- Transaction date: 2026-04-24 (reported on Form 4 filed 2026-04-28).
- Security and amount: 2,286 restricted stock units; acquisition price listed as $0.00 (award).
- Shares owned after transaction: Not specified in this Form 4.
- Footnote: RSUs will be paid one-for-one in Abbott common shares upon the earlier of the director's separation from service, death, or a change in control per the Program.
- Filing timeliness: Report filed 4 days after the grant (appears within typical 2-business-day reporting window for insiders).
Context
- RSU grants to non-employee directors are common compensation and are distinct from open-market purchases or sales; they do not by themselves indicate a director buying or selling stock for investment reasons.
- This was an equity award (not a purchase or sale). The award vests/settles under specified events rather than immediately converting to tradable shares.
Insider Transaction Report
Form 4
Blount Sally E.
Director
Transactions
- Award
Common shares without par value
[F1]2026-04-24+2,286→ 36,344 total
Footnotes (1)
- [F1]Restricted stock unit award granted under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Signature
/s/ Sally E. Blount by Jessica H. Paik, Attorney-in-Fact|2026-04-28